Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
12/28/2011 | EP2399598A1 Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer |
12/28/2011 | EP2398501A1 Use of vgii3 activity modulator for the modulation of adipogenesis |
12/28/2011 | EP2386640A9 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells |
12/28/2011 | EP2109361B1 A transgenic animal and a method of producing it |
12/28/2011 | EP1873240B1 hTERT GENE EXPRESSION REGULATORY GENE |
12/28/2011 | EP1490100B1 Combined dna/protein vaccine compositions |
12/28/2011 | EP1098986B1 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
12/28/2011 | CN1968959B 用于抑制流行性感冒病毒感染的短干扰rna、短发夹rna及编码它们的载体,相关组合物及其应用 Used to inhibit influenza virus infection short interfering rna, rna and short hairpin vectors that encode them, related compositions and its application |
12/28/2011 | CN1966083B 融合基因肿瘤疫苗及构建方法 Fusion gene tumor vaccine and construction methods |
12/28/2011 | CN1820785B 一种抗肿瘤药物 One kind of antineoplastic |
12/28/2011 | CN102300872A 猿腺病毒核酸和氨基酸序列,包含其的载体及其用途 Simian adenovirus nucleic acid and amino acid sequences, including its carrier and its use |
12/28/2011 | CN102296078A 可用于艾滋病治疗的rna干扰靶点 Rna interference can be used for AIDS treatment targets |
12/28/2011 | CN102296067A 靶向cdk1抗ev71、登革、乙脑及流感病毒寡核苷酸的结构和用途 Cdk1 targeted anti ev71, dengue, Japanese encephalitis and influenza virus structure and use of oligonucleotides |
12/28/2011 | CN102296066A 靶向csnk2a2抗ev71、乙脑及流感病毒寡核苷酸的结构和用途 Csnk2a2 targeted anti ev71, encephalitis and influenza virus structure and use of oligonucleotides |
12/28/2011 | CN102295682A Hla-a*1101限制的wt1肽及含有其的药物组合物 Hla-a * 1101 restricted wt1 peptide and a pharmaceutical composition comprising the same |
12/28/2011 | CN102294036A 一种筛选动物抗病毒基因的方法 A method of screening method for animal antiviral gene |
12/28/2011 | CN102294025A 前列腺干细胞抗原多肽与核酸的复合物及其制备方法和应用 Prostate stem cell antigen peptide and nucleic acid compound and preparation method and application |
12/28/2011 | CN101892236B 靶向znf268基因的rna干扰表达载体构建及应用 Rna interference znf268 targeted gene expression vector and its application |
12/28/2011 | CN101368173B 抗人cd44的工程抗体、载体、试剂盒及其用途 Anti-human cd44 engineered antibody, vectors, kits and uses thereof |
12/28/2011 | CN101245350B 密码子优化的轮状病毒蛋白的编码核苷酸序列、其重组体及其应用 Codon optimized nucleotide sequence encoding a rotavirus protein, which recombinant Its Applications |
12/27/2011 | US8084599 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA |
12/27/2011 | US8084589 Phosphoramidite nucleoside analogs |
12/27/2011 | US8084437 Methods for treating hypercholesterolemia |
12/27/2011 | US8084436 Modulation of SGLT2 expression |
12/27/2011 | US8084433 Antisense antiviral compound and method for treating ssRNA viral infection |
12/27/2011 | US8084249 Vector |
12/27/2011 | US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide |
12/22/2011 | WO2011159970A2 Method for predicting a therapy response in subjects with multiple sclerosis |
12/22/2011 | WO2011159960A2 Reprogramming cancer cells |
12/22/2011 | WO2011159958A2 Methods of treatment using tlr7 and/or tlr9 inhibitors |
12/22/2011 | WO2011159865A2 Compositions and methods for using human ykl-40 to treat acute lung injury |
12/22/2011 | WO2011159836A2 Compounds and methods for modulating interaction between proteins and target nucleic acids |
12/22/2011 | WO2011159758A2 Long lasting drug formulations |
12/22/2011 | WO2011159328A1 Methods of treatment using tlr7 and/or tlr9 inhibitors |
12/22/2011 | WO2011158933A1 Agent for treating renal fibrosis |
12/22/2011 | WO2011158924A1 Inhibitor of expression of dominant allele |
12/22/2011 | WO2011157447A2 Modified parvovirus having enhanced anti-tumour efficacy |
12/22/2011 | WO2011143406A3 Parathyroid hormone analogs and uses thereof |
12/22/2011 | WO2011112902A3 Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (viper) |
12/22/2011 | WO2011103011A3 Gene fusion targeted therapy |
12/22/2011 | WO2011088456A3 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery |
12/22/2011 | WO2010111891A8 Modified oligo-nucleic acid molecule, preparation method and uses thereof |
12/22/2011 | US20110313045 Histone deacetylases, and uses related thereto |
12/22/2011 | US20110313028 Suppressor of ap-1 |
12/22/2011 | US20110313027 Methods and substances for stimulating muscle regeneration |
12/22/2011 | US20110313024 RNA INTERFERENCE MEDIATED INHIBITION OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
12/22/2011 | US20110313017 Snalp formulations containing polyoxazoline-dialkyloxypropyl conjugates |
12/22/2011 | US20110312086 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
12/22/2011 | US20110311583 Novel lipids and compositions for the delivery of therapeutics |
12/22/2011 | US20110311580 Settings for recombinant adenoviral-based vaccines |
12/22/2011 | US20110311541 Mutant proteins of the f protein of piv-5 and piv-2 |
12/22/2011 | US20110311530 Truncated baff receptors |
12/22/2011 | US20110311489 Optically-based stimulation of target cells and modifications thereto |
12/22/2011 | US20110311487 Delivery of therapeutic agents to the bone |
12/22/2011 | US20110311473 Methods of treating cognitive impairment |
12/22/2011 | CA2802999A1 Method for predicting a therapy response in subjects with multiple sclerosis |
12/22/2011 | CA2802726A1 Long lasting drug formulations |
12/22/2011 | CA2802599A1 Modified parvovirus having enhanced anti-tumour efficacy |
12/22/2011 | CA2802414A1 Agent for treating renal fibrosis |
12/21/2011 | EP2397563A2 Enhanced antisense oligonucleotides |
12/21/2011 | EP2397555A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
12/21/2011 | EP2397549A2 Non-stochastic generation of genetic vaccines and enzymes |
12/21/2011 | EP2397542A1 Modified parvovirus having enhanced anti-tumour efficacy |
12/21/2011 | EP2397487A1 Short-chain cationic polyamino acid and use thereof |
12/21/2011 | EP2397486A1 Phytases, nucleic acids encoding them and methods for making and using them |
12/21/2011 | EP2397157A1 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor |
12/21/2011 | EP2397148A2 Compositions and methods for the treatment of ophthalmic disease |
12/21/2011 | EP2397146A1 Parvovirus for treatment of tumours by intranasal application |
12/21/2011 | EP2397123A1 Nanoparticles for nucleic acid delivery |
12/21/2011 | EP2396365A2 Reducible polymers for non-viral gene delivery |
12/21/2011 | EP2396038A2 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
12/21/2011 | EP1919511B1 Biologic device for regulation of gene expression |
12/21/2011 | EP1454142B1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
12/21/2011 | EP1386152B1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
12/21/2011 | CN1685063B 与基因沉默相关的方法和组合物 Associated with gene silencing methods and compositions |
12/21/2011 | CN102292106A Il-6抗体及其用途 Il-6 antibody and uses thereof |
12/21/2011 | CN102292102A 免疫应答的引发 Eliciting an immune response |
12/21/2011 | CN102292092A 致敏细胞疗法 Sensitized cell therapy |
12/21/2011 | CN102286465A 一种抑制口蹄疫病毒增殖的猪ifitm3基因及构建方法和应用 A method of inhibiting the proliferation of pig ifitm3 FMDV gene and construction method and application |
12/21/2011 | CN102286433A 一种新型溶瘤腺病毒-胸苷激酶基因构建体的获得及用途 A novel oncolytic adenovirus - Construction of thymidine kinase gene and uses obtained body |
12/21/2011 | CN102286107A 一种高效表达重组丙型肝炎病毒多表位抗原的方法和应用 An efficient expression of recombinant hepatitis C virus multi-epitope approach and application |
12/21/2011 | CN102286104A Hpv6型l2n120e7e6融合蛋白基因、表达载体、方法、菌株和用途 Hpv6 type l2n120e7e6 fusion protein gene, expression vectors, methods, and uses of the strain |
12/21/2011 | CN102286083A 分泌型肺炎链球菌蛋白质 Secreted proteins of Streptococcus pneumoniae |
12/21/2011 | CN102284065A 壳聚糖猪流感dna疫苗纳米粒的制备方法 Preparation of chitosan nanoparticles swine flu vaccine dna |
12/21/2011 | CN102284064A 带afp启动子的腺病毒载体介导的il-24在制备肝癌靶向性基因治疗药物中的应用 Adenoviral vectors with afp promoter mediated il-24 used in the preparation of liver targeting gene therapy in |
12/21/2011 | CN102284058A 复制缺陷型抗ev71和ca16病毒双价疫苗的制备方法 Replication-defective anti ev71 and preparation methods ca16 bivalent vaccine virus |
12/21/2011 | CN101940551B 一种巯基化壳聚糖季胺盐自组装纳米粒、其制备方法及应用 One kind of thiolated chitosan nanoparticles self-assembled quaternary ammonium salt, its preparation method and application |
12/21/2011 | CN101633698B 一种免疫融合蛋白及其编码基因与应用 A protein coding gene and application of immunological fusion |
12/21/2011 | CN101457222B 用于抑制和杀灭耐药性细菌的双链小分子干扰核酸及其组合 Double-stranded small molecules used to inhibit and kill bacterial resistance interfering nucleic acid, and combinations thereof |
12/20/2011 | US8080636 BSL3 antibodies |
12/20/2011 | US8080554 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
12/20/2011 | US8080402 Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase |
12/20/2011 | US8080388 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
12/20/2011 | US8080376 Gene expression control DNA element and associated protein |
12/20/2011 | CA2447450C Corona-virus-like particles comprising functionally deleted genomes |
12/20/2011 | CA2423045C Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
12/20/2011 | CA2386858C 36p6d5: secreted tumor antigen |
12/20/2011 | CA2362454C Viral vectors and viral vaccines based on recombinant porcine adenoviruses |
12/20/2011 | CA2353787C An improved method for the production and purification of adenoviral vectors |
12/20/2011 | CA2321161C Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |